Skip to main content
Sun Pharma up 4% as US arms Taro Pharma resolves antitrust investigation - Business Standard 25-Jul-2020
Sun Pharma up 4% as US arms Taro Pharma resolves antitrust investigation - Business Standard
Taro Pharma has reached a settlement agreement with the US Department of Justice, Antitrust and Civil divisions to pay more than $200 million to settle the generic drug price fixing allegations
More...